Hubei Soundny Biotechnology Overview

  • Year Founded
  • 2009

Year Founded

  • Status
  • Private

  • Employees
  • 88

Employees

  • Latest Deal Type
  • Later Stage VC

  • Latest Deal Amount
  • $3.17M

  • Investors
  • 4

Hubei Soundny Biotechnology General Information

Description

Developer of a drug-loaded vesicle treatment intended to treat tumor. The company's treatment basically focuses on the tumor cells with chemotherapeutic drugs, enabling patients to get proper cure in an enhanced manner.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Formerly Angel backed
Corporate Office
  • 13th Floor, Block C
  • New World Center, 634 Jiefang Avenue
  • Wuhan, Hubei
  • China
+86 027
Primary Industry
Drug Delivery
Other Industries
Biotechnology
Vertical(s)
Corporate Office
  • 13th Floor, Block C
  • New World Center, 634 Jiefang Avenue
  • Wuhan, Hubei
  • China
+86 027

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Hubei Soundny Biotechnology Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Later Stage VC 14-Dec-2018 $3.17M Completed Generating Revenue
4. Later Stage VC 31-Jul-2017 Completed Generating Revenue
3. IPO 06-Feb-2017 Completed Generating Revenue
2. Later Stage VC 09-Mar-2016 $3.42M $4.23M Completed Generating Revenue
1. Later Stage VC 15-Aug-2014 $809K $809K Completed Generating Revenue
To view Hubei Soundny Biotechnology’s complete valuation and funding history, request access »

Hubei Soundny Biotechnology Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Ordinary
Ordinary
Ordinary 27,380,000 $0.14 $0.14 1x $0.14 28.52%
To view Hubei Soundny Biotechnology’s complete cap table history, request access »

Hubei Soundny Biotechnology Patents

Hubei Soundny Biotechnology Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2018145588-A1 Use of cell vesicle formulation combined with low dose radiotherapy in preparation of antitumor drugs Inactive 09-Feb-2017
WO-2018130108-A1 Oral tumor vaccine and use thereof Inactive 12-Jan-2017
US-20190224238-A1 Tumor therapeutic drug Inactive 05-Sep-2016
WO-2018041261-A1 Tumor therapeutic drug Inactive 05-Sep-2016
EP-3305310-A1 Oncolytic virus formulation and preparation method thereof Active 29-May-2015 A61K9/5068
To view Hubei Soundny Biotechnology’s complete patent history, request access »

Hubei Soundny Biotechnology Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Hubei Soundny Biotechnology Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds
China Science & Merchants Investment Management Group PE/Buyout Minority
Wuhan Institute of Biotechnology Government Minority
Wuhan Optics Valley Elite Investment Management Venture Capital Minority
Huasheng Yihong Venture Capital Minority
To view Hubei Soundny Biotechnology’s complete investors history, request access »

Hubei Soundny Biotechnology FAQs

  • When was Hubei Soundny Biotechnology founded?

    Hubei Soundny Biotechnology was founded in 2009.

  • Where is Hubei Soundny Biotechnology headquartered?

    Hubei Soundny Biotechnology is headquartered in Wuhan, China.

  • What is the size of Hubei Soundny Biotechnology?

    Hubei Soundny Biotechnology has 88 total employees.

  • What industry is Hubei Soundny Biotechnology in?

    Hubei Soundny Biotechnology’s primary industry is Drug Delivery.

  • Is Hubei Soundny Biotechnology a private or public company?

    Hubei Soundny Biotechnology is a Private company.

  • What is the current valuation of Hubei Soundny Biotechnology?

    The current valuation of Hubei Soundny Biotechnology is .

  • What is Hubei Soundny Biotechnology’s current revenue?

    The current revenue for Hubei Soundny Biotechnology is .

  • How much funding has Hubei Soundny Biotechnology raised over time?

    Hubei Soundny Biotechnology has raised $18.8M.

  • Who are Hubei Soundny Biotechnology’s investors?

    China Science & Merchants Investment Management Group, Wuhan Institute of Biotechnology, Wuhan Optics Valley Elite Investment Management, and Huasheng Yihong have invested in Hubei Soundny Biotechnology.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process